Form D · Pharmaceuticals

Vensun Pharmaceuticals, Inc.

Yardley, PA · CIK 0001545448

Offering snapshot reported Dec 5, 2016 · SEC filing

Reported sold: $19.5M
Investors reported: 10
Minimum accepted: $0
First sale: Nov 21, 2016

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 5, 2016	Initial	$19,499,991	No comparison	10	SEC filing
Oct 7, 2015	Initial	$4,000,000	No comparison	15	SEC filing
Oct 11, 2013	Initial	$10,669,998	No comparison	6	SEC filing
Mar 28, 2012	Initial	$5,708,000	No comparison	5	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $995K (estimated)
Finders' fees: $0
Form D file number: 021-275666

$995,000 in sales commission has been paid to Leerink Partners LLC in connection with the amount sold. Additional fees may be paid to Leerink Partners LLC in connection with the amount remaining to be sold.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Leerink Partners LLC	39011

Source: Form D, filed Dec 5, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Syed E. Abidi	Director
Michael Altman	Director
Kamlesh Haribhakti	Director
Hemanshu Pandya	Director, Executive
Edward Schutter	Director
Dhananjay G. Wadekar	Director
Jason Wild	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

790 Township Line Rd., Suite 250
Yardley, PA, 19067